|Bid||165.300 x N/A|
|Ask||165.400 x N/A|
|Day's Range||163.000 - 167.400|
|52 Week Range||92.500 - 212.000|
|Beta (5Y Monthly)||0.23|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||0.36 (0.22%)|
|Ex-Dividend Date||Jun 01, 2021|
|1y Target Est||213.59|
Subscribe to Yahoo Finance Plus to view Fair Value for 3759.HKLearn more
Pharmaron Acquires State-of-the-Art Biomanufacturing Site in the United Kingdom from AbbVie
Wuxi Biortus Biosciences Co. Ltd. ("Biortus"), a global leader in structural biology service for drug discovery, recently closed round A financing with US$15 million investment led by Bayland Capital, and the fund will be used to establish a global cryo-EM innovation center.
Pharmaron announces the acquisition of Absorption Systems in the USA.